Press Releases Poxel

Equities

Real-time Euronext Paris Other stock markets 04:32:11 2024-04-29 am EDT			5-day change	1st Jan Change
0.651 ^EUR	-3.27%		-17.70%	+18.15%

Apr. 11	Poxel: CDC falls below the 10% threshold	CF
Feb. 15	Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Poxel to Report Its 2023 Annual Results by the End of April 2024	Mar. 28	BU
Poxel Announces its Financial Calendar for 2024	Jan. 04	AQ
Poxel Provides Corporate Update	Dec. 22	AQ
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023	Nov. 09	AQ
Adrenoleukodystrophy Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	23-10-27	AQ
Poxel : Inside Information / Other news releases	23-10-12	PU
Poxel : Corporate Presentation	23-10-04	PU
Poxel Announces its Participation at Upcoming Scientific Conference	23-10-03	AQ
Poxel Reports Financial Results for First Half 2023 and Provides a Corporate Update	23-09-26	AQ
Poxel : Inside Information / Other news releases	23-09-07	PU
Poxel : Corporate Presentation	23-09-05	PU
Poxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference	23-07-19	AQ
Poxel : Corporate Presentation	23-07-18	PU
Poxel : Corporate Presentation	23-07-05	PU
Poxel Announces the Approval of a Prospectus for the Listing of New Shares on Euronext Paris	23-07-03	AQ
Poxel : Terms of availability of prospectuses	23-06-30	PU
Poxel : Poxel AGM 2023 – Presentation	23-06-21	PU
Poxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy	23-06-16	AQ
Poxel : Corporate Presentation	23-06-09	PU
Poxel : Director Candidate Identity - Thomas Kuhn	23-05-31	PU

No results for this search